NASDAQ · Key Statistics
CollPlant Biotechnologies Ltd (OPHI) P/E Ratio, ROE & Key Statistics
$3.68
NASDAQ: OPHI
Market Cap $6.96M
Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for CollPlant Biotechnologies Ltd (OPHI), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Per share and size
CollPlant Biotechnologies Ltd (OPHI) statistics — frequently asked questions
How much debt does CollPlant Biotechnologies Ltd carry?
CollPlant Biotechnologies Ltd (OPHI) has a debt-to-equity ratio of 0.00, which compares total borrowings with shareholders' equity.
P/E and ROE of other Medical - Specialties stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.